Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Growth and long-term hormonal therapy.

Spiliotis BE.

Pediatr Endocrinol Rev. 2006 Jan;3 Suppl 1:192-4. Review.

PMID:
16641858
2.

Optimizing estrogen replacement treatment in Turner syndrome.

Rosenfield RL, Perovic N, Devine N, Mauras N, Moshang T, Root AW, Sy JP.

Pediatrics. 1998 Aug;102(2 Pt 3):486-8.

PMID:
9685449
3.

Hormone replacement treatment in Turner syndrome.

Kanaka-Gantenbein C.

Pediatr Endocrinol Rev. 2006 Jan;3 Suppl 1:214-8. Review.

PMID:
16641863
4.

Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.

Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.

Metabolism. 2009 Jan;58(1):1-7. doi: 10.1016/j.metabol.2008.07.016.

PMID:
19059524
5.

Growth and puberty in Turner's syndrome.

Bertelloni S, Baroncelli GI, Fruzzetti F, Spinelli C, Simi P, Saggese G.

J Pediatr Endocrinol Metab. 2003 Mar;16 Suppl 2:307-15. Review.

PMID:
12729409
6.

Pubertal height gain in Ullrich-Turner syndrome.

Bechtold S, Dalla Pozza R, Schmidt H, Bonfig W, Schwarz HP.

J Pediatr Endocrinol Metab. 2006 Aug;19(8):987-93.

PMID:
16995583
7.

Gonadotropin levels in Turner's syndrome: correlation with breast development and hormone replacement therapy.

Alves ST, Gallicchio CT, Guimarães MM, Santos M.

Gynecol Endocrinol. 2003 Aug;17(4):295-301.

PMID:
14503973
8.

Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome.

Davenport ML.

Growth Horm IGF Res. 2006 Jul;16 Suppl A:S91-7. Epub 2006 Jun 2. Review.

PMID:
16735135
9.

Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome.

Davenport ML.

Ann N Y Acad Sci. 2008;1135:126-37. doi: 10.1196/annals.1429.031. Review.

PMID:
18574218
10.

Importance of leuprolide acetate variable dosing for precocious puberty: a range of acceptable suppression.

Cohen D, Janfaza M, Klein KO.

J Pediatr Endocrinol Metab. 2009 Jul;22(7):629-34.

PMID:
19774844
11.

CHARACTERIZATION OF SPONTANEOUS AND INDUCED PUBERTY IN GIRLS WITH TURNER SYNDROME.

Folsom LJ, Slaven JE, Nabhan ZM, Eugster EA.

Endocr Pract. 2017 Jul;23(7):768-774. doi: 10.4158/EP161738.OR. Epub 2017 Mar 23.

PMID:
28332872
12.

Hormonal therapy in a patient with a delayed diagnosis of Turner's syndrome.

Gawlik A, Malecka-Tendera E.

Nat Clin Pract Endocrinol Metab. 2008 Mar;4(3):173-7. doi: 10.1038/ncpendmet0747. Epub 2008 Jan 29.

PMID:
18227816
13.

A novel mutation in the human aromatase gene: insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatment.

Lanfranco F, Zirilli L, Baldi M, Pignatti E, Corneli G, Ghigo E, Aimaretti G, Carani C, Rochira V.

Bone. 2008 Sep;43(3):628-35. doi: 10.1016/j.bone.2008.05.011. Epub 2008 May 23.

PMID:
18590994
14.

The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.

Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A.

Growth Horm IGF Res. 2006 Oct-Dec;16(5-6):332-9. Epub 2006 Oct 25.

PMID:
17067837
15.

Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency.

Janner M, Flück CE, Mullis PE.

Horm Res Paediatr. 2012;78(4):261-8. doi: 10.1159/000341585. Epub 2012 Sep 6.

PMID:
22964562
16.

Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.

Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM.

Clin Endocrinol (Oxf). 2009 Feb;70(2):265-73. doi: 10.1111/j.1365-2265.2008.03446.x.

PMID:
19200215
17.

Bone metabolism markers predict increase in bone mass, height and sitting height during puberty depending on the VDR Fok1 genotype.

Terpstra L, Knol DL, Van Coeverden SC, Delemarre-van de Waal HA.

Clin Endocrinol (Oxf). 2006 Jun;64(6):625-31.

PMID:
16712663
18.

Hormonal development therapy (HDT) in hypogonadism in long-term view.

Heinz M.

Best Pract Res Clin Obstet Gynaecol. 2010 Apr;24(2):149-55. doi: 10.1016/j.bpobgyn.2009.11.013. Epub 2010 Jan 13.

PMID:
20075007
19.

[Turner's syndrome and procreation. Ovarian function and Turner's syndrome].

Pienkowski C, Menendez M, Cartault A, Lorenzini F, Lesourd F, Tauber M.

Gynecol Obstet Fertil. 2008 Oct;36(10):1030-4. doi: 10.1016/j.gyobfe.2008.07.011. Epub 2008 Sep 23. Review. French.

PMID:
18815067

Supplemental Content

Support Center